Table 3 DERP systematic review descriptive statistics
From: Improving reference prioritisation with PICO recognition
Review | Inc. | Exc. | Tot. | Prev. |
|---|---|---|---|---|
ACE Inhibitors | 2544 | 41 | 2503 | 1.61% |
ADHD | 851 | 20 | 831 | 2.35% |
Antihistamines | 310 | 16 | 294 | 5.16% |
Atypical Antipsychotics | 1120 | 146 | 974 | 13.04% |
Beta Blockers | 2072 | 42 | 2030 | 2.03% |
Calcium Channel Blockers | 1218 | 100 | 1118 | 8.21% |
Estrogens | 368 | 80 | 288 | 21.74% |
NSAIDS | 393 | 41 | 352 | 10.43% |
Opioids | 1915 | 15 | 1900 | 0.78% |
Oral Hypoglycemics | 503 | 136 | 367 | 27.04% |
Proton Pump Inhibitors | 1333 | 51 | 1282 | 3.83% |
Skeletal Muscle Relaxants | 1643 | 9 | 1634 | 0.55% |
Statins | 3465 | 85 | 3380 | 2.45% |
Triptans | 671 | 24 | 647 | 3.58% |
Urinary Incontinence | 327 | 40 | 287 | 12.23% |